Close 10 Sep 1505 scanned A
NIFTY 5023,477.80+0.20%
BANK NIFTY56,471.95+0.31%
INDIA VIX11.80-1.05%
MIDCAP 15022,904.25-0.38%
SMALLCAP 25018,433.40+0.01%
NEXT 5072,530.90-0.44%
BREADTH61%above 200-DMA
ADV / DEC558 / 939
NSE close 10 Sep

BODALCHEM

Bodal Chemicals Limited
Small capRs 2,092 crRs 15.8 cr traded a day
Close on 10 September 2026
166.11
−5.00%
52-week range87% of the way up
43.29184.05
Market cap
2,092 cr
P/E (TTM)
30.5×
EPS (TTM)
5.45
Revenue YoY
+56.1%
Q1 FY27
Profit YoY
+218.7%
Net margin
4.3%
+2.2pt vs a year ago
Growth trend
+25.7pt
vs last quarter’s YoY
1 month
+141.5%
Below 52w high
10.8%
RSI (14)
85
overbought
Daily swing
7.6%
average true range
Volume
0.6×
vs 20-day average
Traded
Rs 16 cr
median day
Close200-day averageMaterial filing
50100150Aug 25Oct 25Dec 25Feb 26Apr 26Jun 26Aug 26
260 sessions · hover for the filing behind a move

Key metrics

each ranked against every stock scanned tonight
Above the 200-day average
Top of the universe
+156.7%
One-year return
Top of the universe
+155.6%
Return on capital employed
n/a
Debt to equity
n/a
Profitable quarters, last four
of the last four reported
4 of 4
Cash conversion
cash from operations against reported profit
n/a
Revenue growth, year on year
latest reported quarter
+56.1%
Below the 52-week high
from the highest close of the year
-9.7%
1 week
+10.18%
1 month
+141.51%
3 months
+150.51%
6 months
+273.87%
1 year
+155.55%

The read

written from the numbers on this page
The evidence leans constructive8 supporting, 0 against, 1 worth knowing

Supporting

  • trading 157% above its 200-day average
  • sitting at 87% of its 52-week range, with little overhead supply from trapped buyers
  • up 156% over twelve months
  • matches stretched far above trend, which has beaten the market by +0.87 points over 20 sessions across 27,245 past signals
  • 9 of the scans it matches have a positive measured record
  • 6 independent kinds of evidence agree today, which is uncommon
  • revenue grew 56% year on year in the quarter ending 30 June 2026
  • net margin has widened from 1.2% to 4.3% across four quarters

Against

  • nothing the data supports either way

Worth knowing

  • RSI at 85 is stretched; strong stocks stay stretched for a long time, so this is a note on entry timing, not on direction
What would change this read: a close below 65, its 200-day average; a failure to hold the top of its 52-week range.
Assembled automatically from the figures on this page — the scans matched, their measured record, the filed financials, the derivatives positioning and the peer comparison. It is not a recommendation, no one has spoken to the company, and every claim above can be checked against a number further down this page.

What is working, what is not

from the filings and from the price, with the figure behind every line
Working6

Revenue rose 56.1% year on year, from Rs 454 cr to Rs 709 cr.

+56.1%Rs 454 crRs 709 cr

Bodal Chemicals' net profit rose 218.7% year on year, from Rs 10 cr to Rs 30 cr.

+218.7%Rs 10 crRs 30 cr

Profit grew faster than revenue, +218.7% against +56.1%.

+218.7%+56.1%

Trading 156.7% above its 200-day average, which is the line most investors use to separate a bull phase from a bear one.

+156.7%

Up 155.6% over the past year.

+155.6%

4 different kinds of evidence point at it tonight, not 4 versions of the same one.

4 families
Needs watching1

A warning rule fires on it tonight: stretched far above trend.

Stretched far above trend
Every figure here is computed — from the company’s own filings, or from its own closing prices. Wording of 3 of these 3 filing lines was drafted by a language model, which is given the figures and may not introduce another — any sentence containing a number that did not come from the filings is discarded before it reaches this page.

How it has performed

price return over each window, beside the median NSE stock over the same days
this stockmedian NSE stock, same window+10.2%+11.0 pt vs market1W+141.5%+142.6 pt vs market1M+150.5%+147.8 pt vs market3M+273.9%+257.3 pt vs market6M+155.6%+158.7 pt vs market1Y

What the scans say today

13 of 47 matched on 10 Sep
BODALCHEM matches 13 of the 47 scans today, across 6 different kinds of evidence. Three or more independent families agreeing is uncommon — it is the same test the shortlist on every page uses.

Valuation against its own history

440 sessions since 6 September 2024
16×
median 28×
330×
now 30×
BODALCHEM trades at 30× trailing earnings, above its median of 28× over this window — 9% more expensive than usual. The band runs from the 5th to the 95th percentile, so single-day spikes do not set the edges.
This window is short by the standards of valuation history — it begins where four quarters of filed earnings first exist. A stock can look cheap against two years and expensive against ten.

Recent filings

from the exchange, newest first
Other filing filings were typically +0.01pt vs the market over the next 5 sessions (n=17,202) · AGM / EGM filings were typically +0.17pt vs the market over the next 5 sessions (n=8,423)

The business

from the company’s filed results
Everything below is taken from the company’s own quarterly filing with the exchange — the XBRL document it submitted, not a vendor’s summary of it. Figures in rupees crore.
429443451454480490588709-0.1%5.5%4.3%Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
RevenueNet profit, drawn inside its revenue barNet margin, own scale belowrupees crore, per quarter as filed. Revenue bars start at zero.

Going for it

  • revenue grew 56% against the same quarter a year earlier
  • profit rose 219% year on year
  • revenue rose in 4 of the last 4 quarters

Going against it

  • net margin narrowed from 5.5% to 4.3%
Quarter-by-quarter numbers, as filed
QuarterRevenueProfit before taxNet profitEPSNet margin
Q1 FY27
30 Jun · consolidated
70939302.414.3%
Q4 FY26
31 Mar · consolidated
58836322.555.5%
Q3 FY26
31 Dec · consolidated
490000.020.0%
Q2 FY26
30 Sep · consolidated
480660.471.2%
Q1 FY26
30 Jun · consolidated
45413100.762.1%
Q4 FY25
31 Mar · consolidated
45112151.153.2%
Quarterly filings are unaudited unless stated. Consolidated figures are used where the company files both. A single quarter is a noisy thing — the trend across the column is worth more than the top row.

Where the price stands

the same figures every scan on this site is computed from
Trend
Distance from the averages traders watch. Above all of them is a bull phase; below the 200-day is the line most investors use to say otherwise.
Versus 50-day average+94.6%
Versus 200-day average+156.7%
Below 52-week high-9.7%
Above 52-week low+283.7%
Momentum
How hard it has been pushed lately. Above 70 on RSI is stretched, below 30 is washed out — neither is a signal on its own.
RSI (14)85.4
Higher closes in last 53 of 5
Six-month return+273.87%
Risk and liquidity
What a position costs to hold and to exit. Position sizing starts with the daily swing, not with conviction.
Typical daily swing (ATR)7.64%
Volume versus 20-day0.6x
Median daily turnoverRs 15.8 cr

Recent sessions

what this stock has matched since the engine went live
This is the live record, not the backtest — the scans this stock actually appeared in on each stored session. A name that keeps reappearing is in a persistent condition; a one-day appearance usually is not.
SessionScansWhich
10 Sep6The market's strongest stocks, Beating the market for 6 months, Stretched far above trend, Short averages stacked in order, Above the 200-day EMA, Improving business in an uptrend
9 Sep6The market's strongest stocks, Beating the market for 6 months, Stretched far above trend, Short averages stacked in order, Above the 200-day EMA, Improving business in an uptrend
8 Sep9Rising on most days lately, The market's strongest stocks, Beating the market for 6 months, Made a new 52-week high today, Stretched far above trend, Short averages stacked in order +3
7 Sep10Rising on most days lately, The market's strongest stocks, Beating the market for 6 months, Made a new 52-week high today, Stretched far above trend, Closed at the day's high +4
4 Sep7Rising on most days lately, The market's strongest stocks, Beating the market for 6 months, Stretched far above trend, Short averages stacked in order, Above the 200-day EMA +1
3 Sep7Rising on most days lately, The market's strongest stocks, Beating the market for 6 months, Stretched far above trend, Short averages stacked in order, Above the 200-day EMA +1
2 Sep9Rising on most days lately, The market's strongest stocks, Trading far more than usual, Beating the market for 6 months, Made a new 52-week high today, Stretched far above trend +3
1 Sep6Rising on most days lately, Trading far more than usual, Made a new 52-week high today, Stretched far above trend, Short averages stacked in order, Above the 200-day EMA
31 Aug6Rising on most days lately, Trading far more than usual, Made a new 52-week high today, Stretched far above trend, Short averages stacked in order, Gapped up and held it
28 Aug4Rising on most days lately, Made a new 52-week high today, Stretched far above trend, Short averages stacked in order
27 Aug4Rising on most days lately, Made a new 52-week high today, Closed at the day's high, Short averages stacked in order
26 Aug2Rising on most days lately, Short averages stacked in order